Clinical

Dataset Information

0

A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies


ABSTRACT: This is a Phase 2, open-label, multicenter study whose principal objectives are to evaluate the efficacy and safety/tolerability of poziotinib in five cohorts of 30 previously-treated patients each.

DISEASE(S): Solid Tumor,Glioblastome Multiforme,Colorectal Cancer,Breast Neoplasms,Breast Cancer

PROVIDER: 2322657 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| S-EPMC5693673 | biostudies-literature
| S-EPMC6375935 | biostudies-literature
| S-EPMC6579474 | biostudies-literature
| S-EPMC5961091 | biostudies-literature
| S-EPMC7755410 | biostudies-literature
| S-EPMC7768135 | biostudies-literature
| S-EPMC3191015 | biostudies-literature
| S-EPMC5527853 | biostudies-literature
| S-EPMC9601150 | biostudies-literature